Related Experiment Video
Updated: Aug 7, 2026

Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads
Published on: July 21, 2017
Aquaporin-7 and glycerol permeability as novel obesity drug-target pathways
Gema Frühbeck1, Victoria Catalán, Javier Gómez-Ambrosi
1Department of Endocrinology, Clínica Universitaria and Metabolic Research Laboratory, University of Navarra, c/Irunlarrea 1, 31008 Pamplona, Spain. gfruhbeck@unav.es
Abstract:
Advances in determining the mechanisms that underlie the control of energy balance in mammals have recently been provided by the discovery and characterization of aquaporin-7 (AQP7), a water-glycerol transporter that is present in the plasma membrane of fat-storing cells (adipocytes). Recent studies have shown that the absence of AQP7 expression in fat cells increases glycerol kinase activity, boosting triacylglycerol synthesis and ultimately leading to obesity. Thus, AQP7 operates as a glycerol channel in vivo, whereby adipocyte glycerol permeability has a key role in the regulation of fat accumulation.
Related Concept Videos
Aquaporins
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacogenomics: Identification of New Drug Targets
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
